Evidence map›Paper›PMID 35626070›Full record

ArticleCancers2022

Development of Training Materials for Pathologists to Provide Machine Learning Validation Data of Tumor-Infiltrating Lymphocytes in Breast Cancer.

Victor Garcia, Katherine Elfer, Dieter J E Peeters, Anna Ehinger, Bruce Werness, Amy Ly, Xiaoxian Li, Matthew G Hanna, Kim R M Blenman, Roberto Salgado and 1 more

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Reproducible Reporting of the Collection and Evaluation of Annotations for Artificial Intelligence Models.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2024
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Victor GarciaDivision of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0003-4507-3839
Katherine ElferDivision of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0002-7089-0534
Dieter J E PeetersDepartment of Pathology, Sint-Maarten Hospital, 2800 Mechelen, Belgium.
Anna EhingerDepartment of Genetics and Pathology, Laboratory Medicine, Region Skåne, Lund University, 22185 Lund, Sweden.ORCID 0000-0001-9225-7396
Bruce WernessInova Health System Department of Pathology, Falls Church, VA 22042, USA.
Amy LyDepartment of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
Xiaoxian LiDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA.
Matthew G HannaDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-7536-1746
Kim R M BlenmanDepartment of Internal Medicine, Section of Medical Oncology, School of Medicine and Yale Cancer Center, Yale University, New Haven, CT 06511, USA.
Roberto SalgadoDivision of Research, Peter Mac Callum Cancer Centre, Melbourne, VIC 3000, Australia.
Brandon D GallasDivision of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0001-7332-1620

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
FDA Office of Women's Health FDA-OWH-2021-GallasNCI NIH HHS P30 CA008748Oak Ridge Institute for Science and Education FDA-ORISE-DIDSR 2022
6 · The paper itself

Abstract

The High Throughput Truthing project aims to develop a dataset for validating artificial intelligence and machine learning models (AI/ML) fit for regulatory purposes. The context of this AI/ML validation dataset is the reporting of stromal tumor-infiltrating lymphocytes (sTILs) density evaluations in hematoxylin and eosin-stained invasive breast cancer biopsy specimens. After completing the pilot study, we found notable variability in the sTILs estimates as well as inconsistencies and gaps in the provided training to pathologists. Using the pilot study data and an expert panel, we created custom training materials to improve pathologist annotation quality for the pivotal study. We categorized regions of interest (ROIs) based on their mean sTILs density and selected ROIs with the highest and lowest sTILs variability. In a series of eight one-hour sessions, the expert panel reviewed each ROI and provided verbal density estimates and comments on features that confounded the sTILs evaluation. We aggregated and shaped the comments to identify pitfalls and instructions to improve our training materials. From these selected ROIs, we created a training set and proficiency test set to improve pathologist training with the goal to improve data collection for the pivotal study. We are not exploring AI/ML performance in this paper. Instead, we are creating materials that will train crowd-sourced pathologists to be the reference standard in a pivotal study to create an AI/ML model validation dataset. The issues discussed here are also important for clinicians to understand about the evaluation of sTILs in clinical practice and can provide insight to developers of AI/ML models.

Indexed as

biomarkerexpert panelpathologist training/educationtumor-infiltrating lymphocytesvalidation dataset

Identifiers

PMID35626070
PMCPMC9139395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.